A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer ; volume:15 ; number:3 ; day:20 ; month:6 ; year:2013 ; pages:1-11 ; date:6.2013
Breast cancer research ; 15, Heft 3 (20.6.2013), 1-11, 6.2013
- Creator
-
Serrano, Davide
- Contributor
-
Lazzeroni, Matteo
Gandini, Sara
Macis, Debora
Johansson, Harriet
Gjerde, Jennifer
Lien, Ernst
Feroce, Irene
Pruneri, Giancarlo
Sandri, Maria Teresa
Bassi, Fabio
Brenelli, Fabricio
Luini, Alberto
Cazzaniga, Massimiliano
Varricchio, Clara
Guerrieri-Gonzaga, Aliana
Decensi, Andrea
Bonanni, Bernardo
SpringerLink (Online service)
- DOI
-
10.1186/bcr3439
- URN
-
urn:nbn:de:1111-2016032417685
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Serrano, Davide
- Lazzeroni, Matteo
- Gandini, Sara
- Macis, Debora
- Johansson, Harriet
- Gjerde, Jennifer
- Lien, Ernst
- Feroce, Irene
- Pruneri, Giancarlo
- Sandri, Maria Teresa
- Bassi, Fabio
- Brenelli, Fabricio
- Luini, Alberto
- Cazzaniga, Massimiliano
- Varricchio, Clara
- Guerrieri-Gonzaga, Aliana
- Decensi, Andrea
- Bonanni, Bernardo
- SpringerLink (Online service)
Other Objects (12)
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer